Cheng, K.-J.; Chang, H.-T.; Chern, Y.-B.; Wu, C.-F.; Tsai, J.-P.; Hsu, B.-G.
Serum Endocan Levels as a Risk Factor for Peripheral Artery Disease in Non-Dialysis Patients with Chronic Kidney Disease Stages 3–5. Medicina 2025, 61, 577.
https://doi.org/10.3390/medicina61040577
AMA Style
Cheng K-J, Chang H-T, Chern Y-B, Wu C-F, Tsai J-P, Hsu B-G.
Serum Endocan Levels as a Risk Factor for Peripheral Artery Disease in Non-Dialysis Patients with Chronic Kidney Disease Stages 3–5. Medicina. 2025; 61(4):577.
https://doi.org/10.3390/medicina61040577
Chicago/Turabian Style
Cheng, Kai-Jen, Hsiao-Teng Chang, Yahn-Bor Chern, Chun-Feng Wu, Jen-Pi Tsai, and Bang-Gee Hsu.
2025. "Serum Endocan Levels as a Risk Factor for Peripheral Artery Disease in Non-Dialysis Patients with Chronic Kidney Disease Stages 3–5" Medicina 61, no. 4: 577.
https://doi.org/10.3390/medicina61040577
APA Style
Cheng, K.-J., Chang, H.-T., Chern, Y.-B., Wu, C.-F., Tsai, J.-P., & Hsu, B.-G.
(2025). Serum Endocan Levels as a Risk Factor for Peripheral Artery Disease in Non-Dialysis Patients with Chronic Kidney Disease Stages 3–5. Medicina, 61(4), 577.
https://doi.org/10.3390/medicina61040577